Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OncoSil Pancreatic Cancer Post-marketing Clinical REgistrY (OSPREY)

NCT04493632 is registered in ClinicalTrials.gov with OncoSil Medical Limited as lead sponsor.

NCT NCT04493632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04493632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OncoSil Pancreatic Cancer Post-marketing Clinical REgistrY (OSPREY)
Lead sponsor
OncoSil Medical Limited
Phase
Observational
Overall status
Recruiting
Start date
April 12, 2022
Completion date
October 1, 2027
Enrollment
500 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

digestive system disease, digestive system neoplasm, endocrine gland neoplasm, endocrine system diseases, neoplasms, neoplasms by site, pancreatic diseases, pancreatic neoplasm